1887

Abstract

Post-transplant lymphoproliferative disease (PTLD) biopsy material is rarely available in adequate quantity for research. Therefore, the present study was designed to expand biopsy material in scid mice. Epstein–Barr virus (EBV)+ve PTLD samples from five transplant patients were established in scid mice. PCR analysis of immunoglobulin gene rearrangements demonstrated that four of the five biopsies (80%) gave rise to scid tumours which represented the original tumour cell clones. Immunophenotyping showed that these four biopsies (and all scid tumours) expressed all EBV latent genes and a B lymphoblast phenotype; ≤26% T cells were found in the biopsy material whereas scid tumours showed a paucity of T lymphocytes. RT–PCR analysis revealed expression of IL-2, -4, -6, -10 and IFN-γ in all tumour material, suggesting key roles for these factors in tumour growth. The results show that EBV+ve PTLD material can be expanded in scid mice giving rise to quantities of homogeneous malignant tissue sufficient for research studies.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-1-173
2002-01-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/1/0830173a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-1-173&mimeType=html&fmt=ahah

References

  1. Armitage, J. M., Kormos, R. L., Stuart, R. S., Fricker, F. J., Griffith, B. P., Nalesnik, M., Hardesty, R. L. & Dummer, J. S. ( 1991; ). Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. Journal of Heart and Lung Transplantation 10, 877-886.
    [Google Scholar]
  2. Bosma, G. C., Custer, R. P. & Bosma, M. J. ( 1983; ). A severe combined immunodeficiency mutation in the mouse. Nature 301, 527-530.[CrossRef]
    [Google Scholar]
  3. Cen, H., Williams, P. A., McWilliams, H. P., Breinig, M. C., Ho, M. & McKnight, J. L. C. ( 1993; ). Evidence for restricted Epstein–Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 81, 1393-1403.
    [Google Scholar]
  4. Crawford, D. H. ( 2001; ). Biology and disease associations of Epstein–Barr virus. Philosophical Transactions of the Royal Society of London B Biological Sciences 356, 461-473.[CrossRef]
    [Google Scholar]
  5. Deacon, E. M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A. B. & Young, L. S. ( 1993; ). Epstein–Barr virus and Hodgkin′s disease: transcriptional analysis of virus latency in the malignant cells. Journal of Experimental Medicine 177, 339-349.[CrossRef]
    [Google Scholar]
  6. Gardella, T., Medveczky, P., Sairenji, T. & Mulder, C. ( 1984; ). Detection of circular and linear herpesvirus DNA molecules in mammalian cells by electrophoresis. Journal of Virology 50, 248-254.
    [Google Scholar]
  7. Ho, M., Miller, G., Atchison, R. W., Breinig, M. K., Dummer, J. S., Andiman, W., Starzl, T. E., Eastman, R., Griffith, B. P. & Hardesty, R. L. ( 1985; ). Epstein–Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. Journal of Infectious Diseases 152, 876-886.[CrossRef]
    [Google Scholar]
  8. Howe, J. G. & Steitz, J. A. ( 1986; ). Localization of Epstein–Barr virus-encoded small RNAs by in situ hybridization. Proceedings of the National Academy of Sciences, USA 83, 9006-9010.[CrossRef]
    [Google Scholar]
  9. Hurley, E. A. & Thorley-Lawson, D. A. ( 1988; ). B cell activation and the establishment of Epstein–Barr virus latency. Journal of Experimental Medicine 168, 2059-2075.[CrossRef]
    [Google Scholar]
  10. Itoh, T., Shiota, M., Takanashi, M., Hojo, I., Satoh, H., Matsuzawa, A., Moriyama, T., Watanabe, T., Hirai, K. & Mori, S. ( 1993; ). Engraftment of human non-Hodgkin lymphomas in mice with severe combined immunodeficiency. Cancer 72, 2686-2694.[CrossRef]
    [Google Scholar]
  11. Johannessen, I. & Crawford, D. H. ( 1999; ). In vivo models for Epstein–Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Reviews in Medical Virology 9, 263-277.[CrossRef]
    [Google Scholar]
  12. Johannessen, I., Asghar, M. & Crawford, D. H. ( 2000; ). Essential role for T cells in human B cell lymphoproliferative disease development in SCID mice. British Journal of Haematology 109, 600-610.[CrossRef]
    [Google Scholar]
  13. Kuppers, R., Hansmann, M.-L. & Rajewsky, K. (1995). Micromanipulation and PCR analysis of single cells from tissue sections. In Handbook of Experimental Immunology, pp. 206, 1–4. Edited by D. M. Weir, C. Blackwell & L. A. Herzenberg. Cambridge, MA: Blackwell Scientific.
  14. McCarthy, K., Sloane, J. & Wiedermann, L. ( 1990; ). Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. Journal of Clinical Pathology 43, 429-432.[CrossRef]
    [Google Scholar]
  15. Meggetto, F., Muller, C., Henry, S., Selves, J., Mariame, B., Brousset, P., Saati, T. A. & Delsol, G. ( 1996; ). Epstein–Barr virus (EBV)-associated lymphoproliferations in severe combined immunodeficient mice transplanted with Hodgkin′s disease lymph nodes: implication of EBV+ve bystander B lymphocytes rather than EBV-infected Reed–Sternberg cells. Blood 87, 2435-2442.
    [Google Scholar]
  16. Opelz, G. & Henderson, R. ( 1993; ). Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342, 1514-1516.[CrossRef]
    [Google Scholar]
  17. Oudejans, J. J., Jiwa, M., van den Brule, A. J., Grasser, F. A., Horstman, A., Vos, W., Kluin, P. M., van der Valk, P., Walboomers, J. M. & Meijer, C. J. ( 1995; ). Detection of heterogeneous Epstein–Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. American Journal of Pathology 147, 923-933.
    [Google Scholar]
  18. Perera, S. M., Johannessen, I., Thomas, J. A., Brooks, L. A., Jobe, J. N., Crawford, D. H., Radley-Smith, R. & Phillips, M. ( 1996; ). Growth of Epstein–Barr virus-associated B-lymphoproliferative disease tissue in a severe combined immunodeficient mouse. Blood 88, 1123-1125.
    [Google Scholar]
  19. Perera, S. M., Thomas, J. A., Burke, M. & Crawford, D. H. ( 1998; ). Analysis of the T-cell micro-environment in Epstein–Barr virus-related post-transplantation B lymphoproliferative disease. Journal of Pathology 184, 177-184.[CrossRef]
    [Google Scholar]
  20. Raab-Traub, N. & Flynn, K. ( 1986; ). The structure of the termini of the Epstein–Barr virus as a marker of clonal cellular proliferation. Cell 47, 883-889.[CrossRef]
    [Google Scholar]
  21. Randhawa, P. S., Pietrzak, B., Nalesnik, M. A., Demetris, A. J. & Locker, J. ( 1997; ). Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in scid mice. Hematological Oncology 15, 39-46.[CrossRef]
    [Google Scholar]
  22. Reedman, B. M. & Klein, G. ( 1973; ). Cellular localization of an Epstein–Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11, 499-520.[CrossRef]
    [Google Scholar]
  23. Rubini, J. R., Cronkite, E. P., Bond, V. P. & Fliedner, T. M. ( 1960; ). The metabolism and fate of tritiated thymidine in man. Journal of Clinical Investigation 39, 909-918.[CrossRef]
    [Google Scholar]
  24. Stetler-Stevenson, M., Crush-Stanton, S. & Cossman, J. ( 1990; ). Involvement of the bcl-2 gene in Hodgkin′s disease. Journal of the National Cancer Institute 82, 855-858.[CrossRef]
    [Google Scholar]
  25. Taylor, J. H., Woods, P. S. & Hughes, W. L. ( 1957; ). The organization and duplication of chromosomes as revealed by autoradiographic studies using tritium-labeled thymidine. Proceedings of the National Academy of Sciences, USA 43, 122-128.[CrossRef]
    [Google Scholar]
  26. Thomas, J. A., Hotchin, N. A., Allday, M. J., Amlot, P., Rose, M., Yacoub, M. & Crawford, D. H. ( 1990; ). Immunohistology of Epstein–Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49, 944-953.[CrossRef]
    [Google Scholar]
  27. Van Noorden, S. ( 1986; ). Tissue preparation and immunostaining techniques for light microscopy. In Immunocytochemistry: Modern Methods and Applications , pp. 26-53. Edited by J. M. Polak & S. Van Noorden. Bristol:Wright.
  28. Yamamura, M., Uyemura, K., Deans, R. J., Weinberg, K., Rea, T. H., Bloom, B. R. & Modlin, R. L. ( 1991; ). Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254, 277-279.[CrossRef]
    [Google Scholar]
  29. Yamamura, M., Wang, X. H., Ohmen, J. D., Uyemura, K., Rea, T. H., Bloom, B. R. & Modlin, R. L. ( 1992; ). Cytokine patterns of immunologically mediated tissue damage. Journal of Immunology 149, 1470-1475.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-1-173
Loading
/content/journal/jgv/10.1099/0022-1317-83-1-173
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error